Ginkgo Bioworks Holdings share price logo

Ginkgo Bioworks Holdings

NYSE: DNA

Small Cap

$12.18

-0.65

(-5.11%)

Live

as on

Ginkgo Bioworks Holdings Stock Performance

as on October 2, 2026 at 5:07 am IST

  • Day's Low

    Day's High

    $12.11
    $13.13
    downward going graph

    0.57%

    Downside

    7.80%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.37
    $17.58
    downward going graph

    55.91%

    Downside

    44.33%

    Upside

    downward going graph

Ginkgo Bioworks Holdings share price movements today

Previous Close
$12.83
Open
$12.60
Volume
1.8M
Market Cap
$805.4M
Day's Low - High
$12.11 - $13.13
52 Week Low - High
$5.37 - $17.58

Ginkgo Bioworks Holdings Historical Returns

1 Month Return
+ 85.14 %
3 Month Return
+ 24.81 %
1 Year Return
-12.54 %
3 Year Return
-82.28 %
5 Year Return
-97.21 %

Ginkgo Bioworks Holdings Stock Fundamentals & Key Indicators

Check Ginkgo Bioworks Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$805.4M

EPS (TTM)

-5.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.23

Industry PE ratio

-6.12

PEG Ratio

-0.14

EBITDA

-209.2M

Revenue (TTM)

111.9M

Profit Margin

80.09%

Return On Equity TTM

-60.21%

Ginkgo Bioworks Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ginkgo Bioworks Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sell$805.4M-97.21%-2.2380.09%0.00%
StrongBuy$43.8B604.88%-22.690.00%0.00%
Neutral$81.2B-43.54%-24.76-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$77.3B32.85%17.7984.86%0.49%

Stock Returns calculator for Ginkgo Bioworks Holdings Stock including INR - Dollar returns

The Ginkgo Bioworks Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Ginkgo Bioworks Holdings investment value today

Current value as on today

₹90,172

Returns

-₹9,828

(-9.83%)

Returns from Ginkgo Bioworks Holdings Stock

-₹16,973 (-16.97%)

Dollar Impact

₹7,145 (+7.15%)

Analyst Recommendation on Ginkgo Bioworks Holdings Stock

Based on 3 analysts

SELL

0.00%

Buy

33.33%

Hold

66.67%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'SELL' rating for Ginkgo Bioworks Holdings. Average target price of $7

Ginkgo Bioworks Holdings Share Price Target

Get share price movements and forecasts by analysts on Ginkgo Bioworks Holdings.

What analysts predicted

-74%DOWNSIDE

Target Price

$7

Current Price

$12.18

Analyzed by

3 Analysts

High

$9

Target

$7.00

Low

$5

Ginkgo Bioworks Holdings target price $7, a slight downside of -74% compared to current price of $12.18. According to 3 analysts rating.

Indian Investors' Interest in Ginkgo Bioworks Holdings Stock

Investment in Ginkgo Bioworks Holdings Shares on INDmoney has grown by 82.08% in the last 30 days, indicating increased investment activity.

Time period: to

Change:82.08% versus previous 30 day period

Search interest for Ginkgo Bioworks Holdings Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Ginkgo Bioworks Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
37
56
89
43
48
49
38
33
19
20
Gross Profit
28
42
79
34
36
34
26
41
3
18
Operating Income
-178
-222
-55
-103
-88
-65
-90
-70
-71
-58
EBITDA
-153
-140
-35
-143
-68
-46
-66
-34
-63
-44
Interest Expense
-
-
-
0
-
-
-
-
-
-
Depreciation
12
17
17
15
15
15
14
46
12
12
Income Before Tax
-165
-216
-56
-107
-90
-60
-80
-81
-76
-57
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-165
-217
-56
-107
-90
-60
-80
-80
-82
-46
Net Profit Margin
75.75%
75.59%
88.78%
78.06%
75.07%
70.12%
67.04%
124.40%
18.37%
91.47%

Ginkgo Bioworks Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
54
76
313
477
251
227
170
Gross Profit
54
61
184
273
197
188
138
Operating Income
-71
-137
-1,828
-2,208
-864
-559
-315
EBITDA
-106
-108
-1,806
-2,059
-821
-484
-254
Interest Expense
2
2
2
0
0
0
-
Depreciation
10
13
29
61
71
63
58
Income Before Tax
-119
-124
-1,838
-2,121
-892
-547
-313
Income Tax Expense
0
1
-1
-15
0
0
0
Net Income
-119
-126
-1,830
-2,104
-892
-547
-312
Net Profit Margin
100.00%
79.64%
58.68%
57.25%
78.52%
83.02%
81.48%

Ginkgo Bioworks Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-165
-217
-56
-107
-90
-60
-80
-80
-76
-57
Operating Cash Flow
-89
-84
-103
-42
-51
-40
-31
-47
-46
-44
Investing Cash Flow
-12
-26
-10
-13
-198
-63
-72
95
23
11
Financing Cash Flow
0
0
0
0
0
0
9
8
0
16
Change in Cash
-105
-111
-113
-55
-250
-105
-94
54
-23
-16

Ginkgo Bioworks Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-119
-126
-1,836
-2,106
-892
-547
-312
Operating Cash Flow
-44
-135
-253
-252
-295
-319
-171
Investing Cash Flow
-74
-67
-73
-67
-80
-62
-240
Financing Cash Flow
410
90
1,534
95
-3
-1
17
Change in Cash
291
-112
1,207
-223
-379
-383
-393

Global Institutional Holdings in Ginkgo Bioworks Holdings

Check out the Institutions with significant holdings in Ginkgo Bioworks Holdings.

Funds
Holdings
Andreas Halvorsen
6.46%
Vanguard
4.50%
iShares
4.45%
TIAA-CREF Funds
3.89%
Fidelity Commonwealth Trust II
3.44%

Ginkgo Bioworks Holdings News & Key Events

  • img

    Today's Timeline - 29 September

    Tue, 05:30 PM

    -

    Ginkgo Datapoints and Apheris launch Antibody Developability Consortium to enhance manufacturability and developability risk predictions.

Insights on Ginkgo Bioworks Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -82.58M → -46.70M (in $), with an average increase of 76.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 19.47M → 20.15M (in $), with an average increase of 3.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DNA stock has moved up by 25.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 86.4% return, outperforming this stock by 168.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 597.7% return, outperforming this stock by 610.2%

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
OrganisationGinkgo Bioworks Holdings
Headquarters27 Drydock Avenue, Boston, MA, 02210, US
IndustryBiotechnology
CEOJason Kelly

Key Management of Ginkgo Bioworks Holdings

Name

Title

Mr. Austin Che Ph.D.

Co-Founder & Head of Strategy

Mr. Bartholomew Canton Ph.D.

Co-Founder & CTO

Ms. Karen Tepichin

General Counsel & Secretary

Dr. Reshma P. Shetty

Co-Founder, President & Director

Mr. Steven P. Coen CPA

Chief Financial Officer

Mr. Thomas Knight Jr.

Founder

Ms. Jennifer Wipf

Co-Chief Operating Officer

Mr. Daniel Marshall

Senior Manager of Communications & Ownership

Mr. Brian O'sullivan

Head of Commercial

Dr. Jason Kelly Ph.D.

Co-Founder, Co-COO, CEO & Director

FAQs

What is Ginkgo Bioworks Holdings share price today?

Ginkgo Bioworks Holdings share price today is $12.18 as on . Ginkgo Bioworks Holdings share today touched a day high of $13.13 and a low of $12.11.

What is the 52 week high and 52 week low for Ginkgo Bioworks Holdings share?

Ginkgo Bioworks Holdings share touched a 52 week high of $17.58 on and a 52 week low of $5.37 on . Ginkgo Bioworks Holdings stock price today i.e. is trending at $12.18,which is 30.72% down from its 52 week high and 126.82% up from its 52 week low.

What is Ginkgo Bioworks Holdings's market capitalisation today?

Ginkgo Bioworks Holdings market capitalisation is $0.00T as on .

How to invest in Ginkgo Bioworks Holdings Stock (DNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ginkgo Bioworks Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Ginkgo Bioworks Holdings Stock (DNA) from India?

Indian investors can start investing in Ginkgo Bioworks Holdings (DNA) shares with as little as ₹96.315002441406 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.15 in Ginkgo Bioworks Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Ginkgo Bioworks Holdings share’s latest price of $12.18 as on October 1, 2026 at 11:37 pm IST, you will get 0.8210 shares of Ginkgo Bioworks Holdings. Learn more about fractional shares .

What are the returns that Ginkgo Bioworks Holdings has given to Indian investors in the last 5 years?

Ginkgo Bioworks Holdings stock has given -97.21% share price returns and 29.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?